IIM
Ipswich Investment Management Portfolio holdings
AUM
$414M
This Quarter Return
+4.78%
1 Year Return
+15.04%
3 Year Return
+70.41%
5 Year Return
+132.95%
10 Year Return
+315.52%
AUM
$218M
AUM Growth
+$218M
(-8.2%)
Cap. Flow
-$26.1M
Cap. Flow
% of AUM
-12%
Top 10 Holdings %
Top 10 Hldgs %
34.99%
Holding
155
New
4
Increased
43
Reduced
29
Closed
73
Top Buys
| 1 |
3M
MMM
|
$3.36M |
| 2 |
Exxon Mobil
XOM
|
$2.68M |
| 3 |
AbbVie
ABBV
|
$2.41M |
| 4 |
Union Pacific
UNP
|
$2.07M |
| 5 |
JPMorgan Chase
JPM
|
$2.06M |
Top Sells
| 1 |
Amazon
AMZN
|
$5.53M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$4.44M |
| 3 |
Baxter International
BAX
|
$2.57M |
| 4 |
Oracle
ORCL
|
$1.69M |
| 5 |
Thermo Fisher Scientific
TMO
|
$1.64M |
Sector Composition
| 1 | Healthcare | 17.52% |
| 2 | Technology | 17.25% |
| 3 | Energy | 15.36% |
| 4 | Industrials | 13.57% |
| 5 | Financials | 12.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Merck
MRK
$210B
| $3.16M | 1.45% |
52,119
+3,802
| +8% | +$231K |
|
|
27
Baxter International
BAX
$12.7B
| $2.8M | 1.29% |
37,872
-34,845
| -48% | -$2.57M |
|
28
GSK
GSK
$79.9B
| $2.79M | 1.28% |
69,185
+47,070
| +213% | +$1.9M |
|
|
29
AbbVie
ABBV
$372B
| $2.78M | 1.28% |
29,955
+26,055
| +668% | +$2.41M |
|
30
Accenture
ACN
$162B
| $2.77M | 1.27% |
16,935
+1,845
| +12% | +$302K |
|
31
Schlumberger
SLB
$55B
| $2.64M | 1.21% |
39,386
-5,540
| -12% | -$371K |
|
32
Marsh & McLennan
MMC
$101B
| $2.52M | 1.16% |
30,785
+1,630
| +6% | +$134K |
|
33
Church & Dwight Co
CHD
$22.7B
| $2.46M | 1.13% |
46,241
-959
| -2% | -$51K |
|
|
PX
34
DELISTED
Praxair Inc
PX
| $2.42M | 1.11% |
15,293
+95
| +0.6% | +$15K |
|
35
Labcorp
LH
$23.1B
| $2.39M | 1.1% |
13,282
-1,490
| -10% | -$268K |
|
36
PepsiCo
PEP
$204B
| $2.37M | 1.09% |
21,764
+3,162
| +17% | +$344K |
|
37
Scotiabank
BNS
$77.6B
| $2.27M | 1.04% |
39,655
-6,986
| -15% | -$400K |
|
38
Regenxbio
RGNX
$451M
| $2.24M | 1.03% |
31,271
+9,386
| +43% | +$674K |
|
39
Duke Energy
DUK
$95.3B
| $2.23M | 1.03% |
28,228
+909
| +3% | +$71.9K |
|
40
DuPont de Nemours
DD
$32.2B
| $2.22M | 1.02% |
33,656
+23,045
| +217% | +$1.52M |
|
41
Emerson Electric
EMR
$74.3B
| $2.14M | 0.98% |
30,925
+12,600
| +69% | +$871K |
|
42
Truist Financial
TFC
$60.4B
| $2.11M | 0.97% |
41,781
-2,485
| -6% | -$125K |
|
43
Abbott
ABT
$231B
| $1.96M | 0.9% |
32,125
+28,725
| +845% | +$1.75M |
|
44
Colgate-Palmolive
CL
$67.9B
| $1.93M | 0.89% |
29,832
-249
| -0.8% | -$16.1K |
|
45
IBM
IBM
$227B
| $1.93M | 0.89% |
13,830
+6,550
| +90% | +$915K |
|
46
Novartis
NVS
$245B
| $1.91M | 0.88% |
25,330
+1,500
| +6% | +$113K |
|
47
GE Aerospace
GE
$292B
| $1.91M | 0.88% |
140,101
+38,711
| +38% | +$527K |
|
48
McDonald's
MCD
$224B
| $1.73M | 0.8% |
11,052
+1,070
| +11% | +$168K |
|
49
Akamai
AKAM
$11.3B
| $1.64M | 0.75% |
22,427
+125
| +0.6% | +$9.15K |
|
50
Coca-Cola
KO
$297B
| $1.59M | 0.73% |
36,305
+240
| +0.7% | +$10.5K |
|